Cargando…

Good's syndrome and recurrent leishmaniasis: A case report and review of literature

We report the case of a 56-year-old Caucasian male affected by thymoma and myasthenia gravis that developed recurrent visceral leishmaniasis 11 years after thymectomy. After treatment of each relapse with liposomal amphotericin B the PCR-Leishmania was negative and the patient showed clinical improv...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolomeo, Manlio, Bonura, Silvia, Abbott, Michelle, Anastasia, Antonio, Colomba, Claudia, Cascio, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527582/
https://www.ncbi.nlm.nih.gov/pubmed/33024862
http://dx.doi.org/10.1016/j.heliyon.2020.e05061
_version_ 1783589088637485056
author Tolomeo, Manlio
Bonura, Silvia
Abbott, Michelle
Anastasia, Antonio
Colomba, Claudia
Cascio, Antonio
author_facet Tolomeo, Manlio
Bonura, Silvia
Abbott, Michelle
Anastasia, Antonio
Colomba, Claudia
Cascio, Antonio
author_sort Tolomeo, Manlio
collection PubMed
description We report the case of a 56-year-old Caucasian male affected by thymoma and myasthenia gravis that developed recurrent visceral leishmaniasis 11 years after thymectomy. After treatment of each relapse with liposomal amphotericin B the PCR-Leishmania was negative and the patient showed clinical improvement. An immunologic work-up was performed showing lymphopenia with an important decrease in CD4+ T cells (52 cells/μ) and CD4/CD8 ratio (0.2). HIV test was negative. On the basis of previous thymoma and myasthenia gravis and on the basis of the immunological profile a diagnosis of Good's syndrome was made. Since IFNγ plays a main role in the control of Leishmania infection the production of IFNγ was evaluated. After mitogen stimulation of peripheral blood mononuclear cells the production of IFNγ was lower than normal. This is the second reported case of Good's syndrome with recurrent leishmaniasis and indicates that a definitive cure for leishmaniasis in patients with Good's syndrome is not possible. Immunologic work-up in our patient strongly suggests that relapses could be correlated with the low CD4+ T cell number and with the low IFNγ production. Immunotherapy with IFNγ or with compounds able to block the Th2 interleukin production could be a therapeutic option in these patients.
format Online
Article
Text
id pubmed-7527582
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-75275822020-10-05 Good's syndrome and recurrent leishmaniasis: A case report and review of literature Tolomeo, Manlio Bonura, Silvia Abbott, Michelle Anastasia, Antonio Colomba, Claudia Cascio, Antonio Heliyon Case Report We report the case of a 56-year-old Caucasian male affected by thymoma and myasthenia gravis that developed recurrent visceral leishmaniasis 11 years after thymectomy. After treatment of each relapse with liposomal amphotericin B the PCR-Leishmania was negative and the patient showed clinical improvement. An immunologic work-up was performed showing lymphopenia with an important decrease in CD4+ T cells (52 cells/μ) and CD4/CD8 ratio (0.2). HIV test was negative. On the basis of previous thymoma and myasthenia gravis and on the basis of the immunological profile a diagnosis of Good's syndrome was made. Since IFNγ plays a main role in the control of Leishmania infection the production of IFNγ was evaluated. After mitogen stimulation of peripheral blood mononuclear cells the production of IFNγ was lower than normal. This is the second reported case of Good's syndrome with recurrent leishmaniasis and indicates that a definitive cure for leishmaniasis in patients with Good's syndrome is not possible. Immunologic work-up in our patient strongly suggests that relapses could be correlated with the low CD4+ T cell number and with the low IFNγ production. Immunotherapy with IFNγ or with compounds able to block the Th2 interleukin production could be a therapeutic option in these patients. Elsevier 2020-09-29 /pmc/articles/PMC7527582/ /pubmed/33024862 http://dx.doi.org/10.1016/j.heliyon.2020.e05061 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Tolomeo, Manlio
Bonura, Silvia
Abbott, Michelle
Anastasia, Antonio
Colomba, Claudia
Cascio, Antonio
Good's syndrome and recurrent leishmaniasis: A case report and review of literature
title Good's syndrome and recurrent leishmaniasis: A case report and review of literature
title_full Good's syndrome and recurrent leishmaniasis: A case report and review of literature
title_fullStr Good's syndrome and recurrent leishmaniasis: A case report and review of literature
title_full_unstemmed Good's syndrome and recurrent leishmaniasis: A case report and review of literature
title_short Good's syndrome and recurrent leishmaniasis: A case report and review of literature
title_sort good's syndrome and recurrent leishmaniasis: a case report and review of literature
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527582/
https://www.ncbi.nlm.nih.gov/pubmed/33024862
http://dx.doi.org/10.1016/j.heliyon.2020.e05061
work_keys_str_mv AT tolomeomanlio goodssyndromeandrecurrentleishmaniasisacasereportandreviewofliterature
AT bonurasilvia goodssyndromeandrecurrentleishmaniasisacasereportandreviewofliterature
AT abbottmichelle goodssyndromeandrecurrentleishmaniasisacasereportandreviewofliterature
AT anastasiaantonio goodssyndromeandrecurrentleishmaniasisacasereportandreviewofliterature
AT colombaclaudia goodssyndromeandrecurrentleishmaniasisacasereportandreviewofliterature
AT cascioantonio goodssyndromeandrecurrentleishmaniasisacasereportandreviewofliterature